Description

GLP 3 is a next-generation peptide studied for its multi-receptor activity involving GLP-1, GIP, and glucagon pathways. Unlike single-pathway compounds, GLP 3 is researched for its ability to engage multiple metabolic signaling mechanisms simultaneously.

Because of this broader signaling profile, Retatrutide has become a subject of interest in research exploring metabolic regulation, energy balance, and system-level optimization. Its design reflects a more comprehensive approach to metabolic signaling rather than isolated pathway targeting.

GLP 3 continues to be evaluated in advanced research settings focused on metabolic efficiency, adaptive response, and whole-system coordination.